|
|
|
|
|
|
Sponsored by: |
German Research Foundation |
Information provided by: | German Research Foundation |
ClinicalTrials.gov Identifier: | NCT00646256 |
The aim of the study is to examine whether the efficacy of psychoeducation in patients with schizophrenia or schizoaffective disorders is dependent on their cognitive performance level and if a preceding cognitive training can enhance the therapeutic effects of psychoeducation
Condition | Intervention |
Schizophrenia Delusional Disorders (ICD-10) |
Behavioral: COGPACK training, psychoeducation |
MedlinePlus related topics: | Psychotic Disorders Schizophrenia |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study |
Official Title: | Psychoeducation in Patients With Schizophrenia: Neuropsychological Performance and Cognitive Training as Determinants of Outcome |
Estimated Enrollment: | 120 |
Study Start Date: | February 2006 |
Estimated Primary Completion Date: | December 2008 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
no training: No Intervention | |
COGPACK training: Experimental |
Behavioral: COGPACK training, psychoeducation
Bifocal psychoeducation group program (Munich Psychoses Information Program - PIP) with preceding computerbased cognitive training program (COGPACK)
|
Schizophrenic inpatients are examined shortly after admission with a broad battery of clinical and neurological rating scales and neuropsychological tests. They are then randomized to either standard treatment (including antipsychotic medications, art and occupational therapy, psychotherapy) or to standard treatment plus daily computerbased cognitive training (COGPACK; ten 1-hour sessions over two weeks). After repetition of the broad assessment battery all patients (and some of their family members) take part in a bifocal psychoeducation group program (eight 1-hour sessions over four weeks). Specific pre-post measures are illness knowledge, self and expert ratings of adherence to treatment, insight to the illness, treatment satisfaction. The study also includes a 9-month follow-up, with number of rehospitalizations, days in hospital and psychopathology as the primary outcome measures.
Ages Eligible for Study: | 18 Years to 60 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Contact: Thomas Jahn, Prof. Dr. phil. Dipl.-Psych. | +49 (0)89-4140 4278 | th.jahn@lrz.tum.de |
Germany | |||||
Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klinikum rechts der Isar, Technical University of Munich | Recruiting | ||||
Munich, Germany, 81675 |
German Research Foundation |
Principal Investigator: | Thomas Jahn, Prof. Dr. phil. Dipl.-Psych. | Klinik und Poliklinik für Psychiatrie und Psychotherapie, Klnikum rechts der Isar, Technbical Univesity Munich |
Responsible Party: | Technical University of Munich ( Prof. Dr. phil. Dipl.-Psych. Thomas Jahn ) |
Study ID Numbers: | DFG Ja 680 / 4-2, 4-3 |
First Received: | March 25, 2008 |
Last Updated: | March 25, 2008 |
ClinicalTrials.gov Identifier: | NCT00646256 |
Health Authority: | Germany: Ethics Commission |
|
|
|